However Cologuard has been thriving, you can find problems with Actual Sciences that buyers are unable to overlook. 1st, the company's best-line advancement charge continues to be reducing. In the first quarter, Actual Sciences' earnings of $638 million improved by just below six% year above year.????????????????????????????????????????????????????